Search results
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its...
Simply Wall St. via Yahoo Finance· 2 hours agoAs you might know, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) just kicked off its latest...
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 10 hours agoVertex Pharmaceuticals Inc (NASDAQ:VRTX) showcases robust revenue growth and solid operational...
Vertex First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 hours agoVertex (NASDAQ:VERX) First Quarter 2024 Results Key Financial Results Revenue: US$156.8m (up 18%...
Vertex Resource Group Ltd.'s (CVE:VTX) CEO Compensation Looks Acceptable To Us And Here's Why
Simply Wall St. via Yahoo Finance· 5 hours agoKey Insights Vertex Resource Group to hold its Annual General Meeting on 15th of May Total pay for...
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 1 day agoShares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this...
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 1 day agoAlthough the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the...
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
Zacks via Yahoo Finance· 2 days agoVertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of...
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
Investor's Business Daily· 3 hours agoThe stock market rally had a quiet session for a second straight day. Nvidia fell slightly for a...
Vertex Energy shares dip on wider-than-expected loss in Q1, revenue miss
Investing.com· 10 hours agoVertex Energy, Inc. (NASDAQ: VTNR ), a key player in the specialty refining and marketing of...
Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
Investor's Business Daily· 2 days agoVertex stock advanced Tuesday as analysts debated the company's pain drug, VX-548, with one saying...